In January 2007 my wife was diagnosed with transitional cell cancer of the renal pelvis, with metastasis ("numerous" nodules) to her lungs. Her kidney, ureter, and a small superficial tumor in her bladder were removed.
The hospital oncologist told me it would be a miracle if she lived 6 months because of the extent of her lung metastasis. Statistically, he said, once diagnosed with metastatic TCC, patients generally survive 9 - 13 months with chemotherapy.
There were both "low grade" and "high grade" cells noted on the pathology report. I don't know what causes the difference in high and low, or if it changes for each cell at any time. In any event, TCC is an aggressive cancer.
She went onto an aggressive MVAC regimen with another oncologist who refused to pronounce an expiration date - weekly doses as long as she could stand it (adequate blood cell counts). MVAC is a harsh regimen, and by December 2007 her marrow was too weak to produce adequate hemoglobin and WBC. Her last chemo treatment was in early January 2008. The cancer thrived, and her decline was dramatic.
Karen passed away on 2/8/08 - thirteen months to the day from her diagnosis. She fought hard, and with incredible strength that I don't know how she mustered. We searched everywhere, high and low, for almost a year for all possible options - trials, innovations, etc. Nothing was available because of the extent of her lung metastasis. We were told that any more than three lung nodules made it impossible to treat with radiation or surgery.
I wish there was better news. I wish we could have had better news, or a better chance. TCC doesn't appear to be on anyone's "priority list" for more effective treatment.
I wish you all the best, and a better outcome than ours. I would recommend searching every possible avenue for every possible trial or innovation out there. My heart is with you.
Jack